OQROSign up free
5%+ stake

Kalaris Therapeutics (KLRS): Coastlands Capital LP now owns 5.7% of KLRS as a passive investor 5.7%

Coastlands Capital LP now owns 5.7% of KLRS as a passive investor.

5.7%
Stake
1.36M
Shares owned
Stake as of
Oct 19, 2026
Filed
Oct 26, 2026

Context

Written by software from the filings listed below · Oct 26, 2026

  • What was filed. Coastlands Capital LP filed a SCHEDULE 13G on Oct 26, 2026 reporting 1,355,119 shares, 5.69% of Kalaris Therapeutics (KLRS).

4 more points, with the facts they come from, are in OQRO Pro.

Sign up free

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

    What came next

    1. Oct 26, 20265% stakeCoastlands Capital LP reported a passive stake (13G) of 5.7%
    2. Nov 10, 2026Company filing · Form 8-K · ResultsReported its results
    View the official recordSEC Schedule 13G

    How to read SEC Schedule 13G

    A Schedule 13D and a Schedule 13G both disclose beneficial ownership of more than 5% of a US company's voting shares. A 13D is the long form, filed by holders who may seek to influence or control the company, and it must state what they intend to do. A 13G is the short form, open only to passive holders and to certain institutions holding in the ordinary course of business, and it asks no question about intent.

    Full guide: Schedule 13D vs Schedule 13G: what is the difference?

    What else is on file for Kalaris Therapeutics

    For Kalaris Therapeutics, OQRO holds 1 fund holdings report (13F) dated in the last 90 days.

    These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its KLRS page.

    How this filing works

    Explore the data

    Other disclosures at Kalaris Therapeutics

    Everything OQRO holds on this company is on its KLRS page.

    This is one filing. OQRO holds the rest

    Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

    Sign up freeAlready have an account? Log in

    OQRO is free for everyone. No card, no trial

    OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data